RESTYLANE INJECTABLE GEL
FDA premarket approval P040024/S068 · decided 2013-03-01
Approval details
- PMA number
- P040024
- Supplement
- S068
- Supplement type
- 30-Day Notice
- Supplement reason
- Process Change - Manufacturer/Sterilizer/Packager/Supplier
- Trade name
- RESTYLANE INJECTABLE GEL
- Generic name
- Implant, dermal, for aesthetic use
- Applicant
- Q-Med AB
- Date received
- 2013-01-31
- Decision date
- 2013-03-01
- Days to decision
- 29 days
- Decision code
- OK30
- Product code
- LMH
- Advisory committee
- General, Plastic Surgery
- Expedited review
- No
- Location
- Uppsala
- Statement
- PROPOSED INTRODUCTION OF A NEW PROCESS VESSEL USED IN THE BULK AND FILLING PROCESS IN FACTORY 2.
Class III intelligence, same tools
PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.